A major concern among patients with cancer is hair loss secondary to chemotherapy, an adverse effect that occurs among approximately 65% of patients who undergo this form of therapy.1 The association between chemotherapy and hair loss is well known across society, and chemotherapy-induced alopecia (CIA) can, therefore, induce a sense of violated privacy, or even shame, among those affected. The association of this adverse effect with reduced self-esteem, social confidence, and sexuality is particularly devastating for women. The anticipation of CIA is so distressing that some female patients even seriously consider refusing chemotherapy treatment.2
Basmanav FB, Nöthen MM, Betz RC. Insights Into the Biology of Persistent Chemotherapy-Induced Alopecia via Genomic Approaches—An Avenue to Clinical Translation? JAMA Dermatol. 2020;156(9):947–948. doi:10.1001/jamadermatol.2020.1866
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.